An adult patient who is the recipient of a kidney transplant is prescribed the antirejection drug mycophenolate. What potential problem should you monitor this patient for?

Question

Quizplus · Accepted Answer

Patients who receive antirejection drugs, such as mycophenolate, have a suppressed immune system. This places them at a higher risk for infections, so healthcare providers should monitor these patients for signs and symptoms of infection.

An Adult Patient Who Is the Recipient of a Kidney